-
Case-Resource Centre
-
Feedback Form for CCK-8 Reagent Trial (Changchun University of Traditional Chinese Medicine)Details
-
Feedback Form for CCK-8 Reagent Trial (Shanghai First People's Hospital)Details
-
Feedback Form for CCK-8 Reagent Trial (Huashi Institute of Brain Functional Genomics)Details
-
Feedback Form for CCK-8 Reagent Trial (Jiading District Central Hospital, Shanghai)Details
-
Feedback Form for CCK-8 Reagent Trial (Shanghai University of Traditional Chinese Medicine)Details
-
Feedback Form for CCK-8 Reagent Trial (Kunming University of Science and Technology)Details
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands